Jose Antonio Porras
Overview
Explore the profile of Jose Antonio Porras including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
651
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dubois-Silva A, Bikdeli B, Jimenez D, Barbagelata-Lopez C, Fernandez-Capitan C, Skride A, et al.
Thorax
. 2025 Mar;
PMID: 40081905
Background: The impact of deep vein thrombosis (DVT) location on acute pulmonary embolism (PE) prognosis remains uncertain. Methods: Using the Registro Informatizado de Enfermedad TromboEmbólica registry, we assessed 30-day and...
2.
Lafaie L, Poenou G, Hanon O, Lopez-Jimenez L, Nieto J, Lorenzo A, et al.
J Am Geriatr Soc
. 2023 Oct;
72(1):113-125.
PMID: 37814983
Background: Age is a major risk factor for venous thromboembolism (VTE), yet patients aged ≥90 years are under-represented in clinical trials of anticoagulant therapy. The objectives were to describe and...
3.
Binetti J, Real M, Renzulli M, Bertran L, Riesco D, Perpinan C, et al.
Viruses
. 2023 Jul;
15(7).
PMID: 37515140
Long COVID (LC) syndrome is a complex multiorgan symptom that persists beyond >12 weeks after SARS-CoV-2 infection. The most frequently associated symptom is fatigue. Physical activity and exercise are recommended,...
4.
Bertran L, Adalid L, Vilaro-Blay M, Barrientos-Riosalido A, Aguilar C, Martinez S, et al.
Metabolites
. 2023 Apr;
13(4).
PMID: 37110154
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic hepatic disease. Although mostly benign, this disease can evolve into nonalcoholic steatohepatitis (NASH). The stimulator of interferon genes (STING) plays...
5.
Di Micco P, Salazar V, Fernandez Capitan C, Dentali F, Gomez Cuervo C, Torres J, et al.
Life (Basel)
. 2022 Aug;
12(8).
PMID: 36013307
Background: The use of rivaroxaban in clinical practice often deviates from manufacturer prescribing information. No studies have demonstrated an association between this practice and improved outcomes. Methods: We used the...
6.
Trujillo-Santos J, Farge-Bancel D, Pedrajas J, Gomez-Cuervo C, Ballaz A, Braester A, et al.
Res Pract Thromb Haemost
. 2022 Jun;
6(4):e12736.
PMID: 35664535
Background: Venous thromboembolism (VTE) is a frequent complication in patients with cancer and a leading cause of morbidity and death. Objectives: The objective of the RIETECAT study was to compare...
7.
Bikdeli B, Jimenez D, Demelo-Rodriguez P, Galeano-Valle F, Porras J, Barba R, et al.
Viruses
. 2022 Feb;
14(2).
PMID: 35215771
Background: Venous thromboembolism (VTE)-including deep vein thrombosis, pulmonary embolism, and cerebral venous sinus thrombosis (CVST)-may occur early after vaccination against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We sought...
8.
Trujillo-Santos J, Beroiz P, Moustafa F, Alonso A, Morejon E, Lopez-Reyes R, et al.
Thromb Res
. 2021 Nov;
208:233.
PMID: 34740456
No abstract available.
9.
Bertran L, Portillo-Carrasquer M, Aguilar C, Porras J, Riesco D, Martinez S, et al.
Int J Mol Sci
. 2021 Jul;
22(13).
PMID: 34198988
Secreted frizzled-related protein 5 (SFRP5), an antagonist of the noncanonical WNT pathway, has a controversial role in liver disease. The aim of this study was to analyze the role of...
10.
Bertran L, Pastor A, Portillo-Carrasquer M, Binetti J, Aguilar C, Martinez S, et al.
Int J Mol Sci
. 2021 Jun;
22(10).
PMID: 34063472
The pathogenic mechanisms underlying nonalcoholic fatty liver disease (NAFLD) are beginning to be understood. RUNX1 is involved in angiogenesis, which is crucial in inflammation, but its role in nonalcoholic steatohepatitis...